Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thalidomide in the Treatment of Chronic Plaque Psoriasis.

NCT01891019 is registered in ClinicalTrials.gov with Wake Forest University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01891019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thalidomide in the Treatment of Chronic Plaque Psoriasis.
Lead sponsor
Wake Forest University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2003
Completion date
June 30, 2009
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis, plaque-type